Allmed Medical Products Co., Ltd (002950SZ) DCF Valuation

Allmed Medical Products Co., Ltd (002950.sz) DCF -Bewertung

CN | Healthcare | Medical - Instruments & Supplies | SHZ
Allmed Medical Products Co., Ltd (002950SZ) DCF Valuation
  • Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • Professional Design: Trusted, Industry-Standard Templates
  • Pre-Built For Quick And Efficient Use
  • No Expertise Is Needed; Easy To Follow

Allmed Medical Products Co., Ltd (002950.SZ) Bundle

Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Möchten Sie den inneren Wert von Allmed Medical Products Co., Ltd schätzen? Unser DCF-Taschenrechner (002950SZ) integriert reale Daten mit umfangreichen Anpassungsfunktionen, mit denen Sie Ihre Prognosen verfeinern und fundiertere Investitionsentscheidungen treffen können.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019
AY2
2020
AY3
2021
AY4
2022
AY5
2023
FY1
2024
FY2
2025
FY3
2026
FY4
2027
FY5
2028
Revenue 2,352.5 3,834.5 2,925.6 4,210.5 2,756.7 2,889.4 3,028.6 3,174.5 3,327.3 3,487.6
Revenue Growth, % 0 63 -23.7 43.92 -34.53 4.82 4.82 4.82 4.82 4.82
EBITDA 558.4 1,491.7 672.9 696.7 422.2 679.0 711.7 746.0 781.9 819.6
EBITDA, % 23.74 38.9 23 16.55 15.32 23.5 23.5 23.5 23.5 23.5
Depreciation 121.6 142.6 147.9 194.8 227.4 155.0 162.4 170.3 178.5 187.0
Depreciation, % 5.17 3.72 5.06 4.63 8.25 5.36 5.36 5.36 5.36 5.36
EBIT 436.8 1,349.1 524.9 501.9 194.9 524.1 549.3 575.8 603.5 632.6
EBIT, % 18.57 35.18 17.94 11.92 7.07 18.14 18.14 18.14 18.14 18.14
Total Cash 243.6 1,337.8 686.6 786.8 493.9 608.6 637.9 668.6 700.8 734.6
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 384.1 295.6 532.5 521.6 493.3
Account Receivables, % 16.33 7.71 18.2 12.39 17.89
Inventories 708.6 707.3 846.6 877.3 707.2 716.6 751.1 787.2 825.2 864.9
Inventories, % 30.12 18.45 28.94 20.84 25.65 24.8 24.8 24.8 24.8 24.8
Accounts Payable 107.6 143.9 253.9 897.3 326.1 289.8 303.7 318.3 333.7 349.8
Accounts Payable, % 4.57 3.75 8.68 21.31 11.83 10.03 10.03 10.03 10.03 10.03
Capital Expenditure -232.6 -243.3 -290.7 -398.0 -286.5 -265.9 -278.7 -292.1 -306.2 -320.9
Capital Expenditure, % -9.89 -6.34 -9.94 -9.45 -10.39 -9.2 -9.2 -9.2 -9.2 -9.2
Tax Rate, % 34.69 34.69 34.69 34.69 34.69 34.69 34.69 34.69 34.69 34.69
EBITAT 361.1 1,166.6 447.8 421.1 127.3 423.1 443.4 464.8 487.2 510.6
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -735.0 1,192.0 38.8 841.4 -304.6 340.7 286.4 300.2 314.7 329.8
WACC, % 6.32 6.34 6.33 6.33 6.22 6.31 6.31 6.31 6.31 6.31
PV UFCF
SUM PV UFCF 1,313.1
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 336
Terminal Value 7,810
Present Terminal Value 5,752
Enterprise Value 7,065
Net Debt 503
Equity Value 6,561
Diluted Shares Outstanding, MM 633
Equity Value Per Share 10.36

Benefits of Choosing Allmed Medical Products Co., Ltd (002950SZ)

  • Comprehensive Financial Data: Access both historical and projected data for precise evaluation.
  • Customizable Parameters: Adjust key factors like WACC, tax rates, revenue growth, and capital investments.
  • Real-Time Calculations: Automatically computes intrinsic value and NPV as inputs change.
  • Scenario Planning: Explore various scenarios to assess the future outlook of Allmed Medical Products Co., Ltd (002950SZ).
  • User-Friendly Interface: Designed for industry professionals while remaining easy to navigate for newcomers.

Key Features

  • 🔍 Real-Life (002950SZ) Financials: Pre-filled historical and projected data for Allmed Medical Products Co., Ltd.
  • ✏️ Fully Customizable Inputs: Adjust all essential parameters (yellow cells) such as WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Integrated formulas calculate Allmed’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Allmed’s valuation immediately after making adjustments.
  • Scenario Analysis: Evaluate and compare different outcomes for various financial assumptions side-by-side.

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Examine Allmed Medical Products Co., Ltd's (002950SZ) pre-filled financial information and projections.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model updating in real-time as you modify your assumptions.
  5. Step 5: Review the outputs and leverage the findings for your investment strategies.

Why Choose This Calculator for Allmed Medical Products Co., Ltd (002950SZ)?

  • Designed for Experts: A sophisticated tool utilized by healthcare analysts, CFOs, and industry consultants.
  • Accurate Financial Data: Allmed's historical and projected financial information preloaded for reliable analysis.
  • Flexible Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
  • Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential financial metrics.
  • User-Friendly: Detailed instructions walk you through each step of the process.

Who Can Benefit from Allmed Medical Products Co., Ltd (002950SZ)?

  • Medical Students: Gain hands-on experience with valuation methods using real industry data.
  • Researchers: Utilize established models in your studies or academic projects.
  • Investors: Validate your investment strategies and evaluate valuation metrics for Allmed Medical Products (002950SZ).
  • Market Analysts: Enhance your efficiency with a ready-to-use, customizable DCF model tailored for healthcare companies.
  • Healthcare Entrepreneurs: Discover how publicly traded firms like Allmed are assessed in the market.

Contents of the Template

  • Comprehensive DCF Model: Editable template featuring detailed valuation calculations.
  • Real-World Data: Historical and projected financial data for Allmed Medical Products Co., Ltd (002950SZ) preloaded for thorough analysis.
  • Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore different scenarios.
  • Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
  • Key Ratios: Integrated analysis of profitability, efficiency, and leverage metrics.
  • Dashboard with Visual Outputs: Visualizations such as charts and tables for clear, actionable conclusions.


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.